Daniel J. Curran
Director at Catalyst Pharmaceuticals, Inc. (CPRX) since August 2025
Daniel J. Curran has filed 9 insider reports with the SEC since June 2024, as director at Catalyst Pharmaceuticals, Inc. (CPRX), director at Xilio Therapeutics, Inc. (XLO) and director at Alx Oncology Holdings Inc (ALXO). The latest filing, on July 17, 2026, reports sale back to the company at Catalyst Pharmaceuticals, Inc. (CPRX).
- Filings
- 9
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Daniel J. Curran is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince August 2025 | 0 | Jul 17, 2026 | |||||
| Director | $7.63 | Jun 12, 2026 | |||||
| Directorsince August 2025 | $0.9701 | Jan 21, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 15, 2026CPRXSEC Form 4 filed by Director Curran Daniel J. to cover taxesForm 4Sale back to the company
- Jun 11, 2026XLOSEC Form 4 filed by Director Curran Daniel J.Form 4Grant or award
- Jan 20, 2026ALXOSEC Form 4 filed by Director Curran Daniel J.Form 4Grant or award
- Nov 20, 2025CPRXSEC Form 4 filed by Director Curran Daniel J.Form 4Grant or award
- Aug 12, 2025ALXOSEC Form 4 filed by Director Curran Daniel J.Form 4Grant or award
- Aug 12, 2025ALXODaniel J. Curran became an insiderForm 3New insider
- Aug 1, 2025CPRXNew insider Curran Daniel J. claimed no ownership of stock in the companyForm 3New insider
- Jun 11, 2025XLOSEC Form 4 filed by Director Curran Daniel J.Form 4Grant or award
Compare Daniel J. Curran with
- Daniel J. Curran vs Yariv Houvras1 shared
- Daniel J. Curran vs Jason Lettmann1 shared
- Daniel J. Curran vs Shelly Wong1 shared
- Daniel J. Curran vs Gregg Russo1 shared
- Daniel J. Curran vs Brian Elsbernd1 shared
- Daniel J. Curran vs Tamar Thompson1 shared
Other insiders at the same companies
- Yariv HouvrasXLO
- Jason LettmannALXO
- Shelly WongALXO
- Gregg RussoCPRX
- Tamar ThompsonCPRX
- Steve MillerCPRX
- Brian ElsberndCPRX
- David S TierneyCPRX
- Richard J DalyCPRX
- Preethi SundaramCPRX
- Jeffrey Del CarmenCPRX
- Patrick J McenanyCPRX
- William T. AndrewsCPRX
- Donald A DenkhausCPRX
- Michael Wayne KalbCPRX
- Molly HarperCPRX
Questions about Daniel J. Curran
- What is Daniel J. Curran's role at Catalyst Pharmaceuticals, Inc.?
- Daniel J. Curran reports to the SEC as director at Catalyst Pharmaceuticals, Inc. (CPRX), according to the latest filing on July 17, 2026. Daniel J. Curran has also filed as director at Xilio Therapeutics, Inc. (XLO) and director at Alx Oncology Holdings Inc (ALXO).
- Has Daniel J. Curran bought or sold stock recently?
- No open-market purchases or sales by Daniel J. Curran are on file. The filings report sale back to the company and grant or award.
- How do I get alerts when Daniel J. Curran files?
- Follow Daniel J. Curran on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Daniel J. Curran (SEC CIK 0001887599). Totals count each trade once, skipping amendments whose original is on file, from Jun 17, 2024 on. View on SEC EDGAR